Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
RESEARCH TOOLSreports
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?
475 Followers
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview
19.15% Insiders
33.76% Mutual Funds
43.58% Other Institutional Investors
3.50% Public Companies and
Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail and individual investors. Approximately 77.35% of the company’s stock is owned by Institutional Investors, 19.15% is owned by Insiders and 3.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 05, 2024 | Xichen Lin Cso | Sold | $5600988 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $9343 | |
| Mar 31, 2024 | Bought | $191327 | |
| Mar 31, 2024 | Bought | $7710171 | |
| Mar 31, 2024 | Bought | $44303524 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,353,259 | Institution | 5.88% | 126,652,592 | |
| 2,953,015 | Institution | 5.18% | 111,535,377 | |
| 2,490,303 | Institution | 4.37% | 94,058,744 | |
| 2,239,384 | Institution | 3.93% | 84,581,534 | |
| 1,510,362 | Institution | 2.65% | 57,046,373 | |
| 1,033,680 | Institution | 1.81% | 39,042,094 | |
| 912,404 | Institution | 1.60% | 34,461,499 | |
| 785,626 | Institution | 1.38% | 29,673,094 | |
| 721,524 | Institution | 1.26% | 27,251,961 | |
| 697,397 | Institution | 1.22% | 26,340,685 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,353,259 | Institution | 5.88% | 126,652,592 | |
| 2,953,015 | Institution | 5.18% | 111,535,377 | |
| 2,239,384 | Institution | 3.93% | 84,581,534 | |
| 912,404 | Institution | 1.60% | 34,461,499 | |
| 785,626 | Institution | 1.38% | 29,673,094 | |
| 721,524 | Institution | 1.26% | 27,251,961 | |
| 697,397 | Institution | 1.22% | 26,340,685 | |
| 647,300 | Institution | 1.13% | 24,448,521 | |
| 629,033 | Institution | 1.10% | 23,758,576 | |
| 528,900 | Institution | 0.93% | 19,976,553 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 264,670 | Institution | 0.46% | 9,911,892 | |
| 28,240 | Institution | 0.05% | 1,093,735 | |
| 27,865 | Institution | 0.05% | 1,043,544 | |
| 19,327 | Institution | 0.03% | 828,355 | |
| 14,082 | Institution | 0.02% | 545,396 | |
| 15,865 | Institution | 0.03% | 542,583 | |
| 10,472 | Institution | 0.02% | 392,176 | |
| 9,096 | Institution | 0.02% | 352,288 | |
| 7,240 | Institution | 0.01% | 280,405 | |
| 6,300 | Institution | 0.01% | 243,999 |
FAQ
Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 43.58% of the company's stock is held by institutional investors, 19.15% is held by insiders, and 3.50% is held by retail investors.
What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.58% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
According to the latest TipRanks data, approximately 3.50% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
SMALLCAP World Fund Inc owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.